EQS-NVR: Dermapharm Holding SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Summary by AI ^BETAClose X

Dermapharm Holding SE has announced a new total of 49,540,810 voting rights, effective April 16, 2026, as per Article 41 of the German Securities Trading Act. This announcement follows an "other (capital) measure" and does not include any multiple voting rights.

Disclaimer*

EQS Total Voting Rights Announcement: Dermapharm Holding SE / Total Voting Rights Announcement
Dermapharm Holding SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

20.04.2026 / 11:50 CET/CEST
Total Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Publication of new total number of voting rights according to Sec. 41 WpHG

1. Details of issuer

Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany

2. Type of capital measure or other measure

	Type of capital measure or other measure	Date of status / date of effect
	Conditional capital increase (Sec. 41 para. 2 WpHG)
X	Other (capital) measure (Sec. 41 para. 1 WpHG)	16 Apr 2026

3. New total number of voting rights:

49.540.810
number of multiple voting rights thereof: 0

20.04.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News